Aditya Shreenivas

Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT

M. Aljurf, R. Gale, N. Callander, 2019, Bone Marrow Transplantation.

Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European S

M. Aljurf, R. Gale, N. Callander, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Emerging drugs for the treatment of Myelofibrosis

J. Mascarenhas, A. Shreenivas, Aditya Shreenivas, 2018, Expert opinion on emerging drugs.

Blood and marrow transplant within 4 weeks of SARS-CoV-2 infection is associated with increased risk of mortality: a National COVID Cohort Collaborative (N3C) Study

S. Chhabra, B. Dhakal, S. Radhakrishnan, 2023, Bone marrow transplantation.